Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.30)
# 2,704
Out of 4,996 analysts
241
Total ratings
45%
Success rate
-3.31%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Technologies | Initiates: In-Line | $185 | $170.81 | +8.31% | 1 | Sep 23, 2025 | |
| PEN Penumbra | Initiates: Outperform | $300 | $253.37 | +18.40% | 1 | Sep 2, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $130 → $128 | $123.39 | +3.74% | 6 | Aug 28, 2025 | |
| CAI Caris Life Sciences | Maintains: Outperform | $33 → $40 | $29.19 | +37.03% | 2 | Aug 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $68 → $64 | $53.57 | +19.47% | 6 | Aug 8, 2025 | |
| AZTA Azenta | Maintains: In-Line | $35 → $33 | $28.54 | +15.63% | 8 | Aug 5, 2025 | |
| MTD Mettler-Toledo International | Maintains: Outperform | $1,280 → $1,275 | $1,204.43 | +5.86% | 11 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $18 → $16 | $11.84 | +35.14% | 11 | Aug 4, 2025 | |
| EW Edwards Lifesciences | Maintains: In-Line | $77 → $80 | $76.25 | +4.92% | 13 | Jul 25, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $145 → $140 | $133.55 | +4.83% | 15 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $102 → $96 | $98.24 | -2.28% | 13 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $500 → $480 | $464.24 | +3.39% | 12 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $390 → $415 | $369.02 | +12.46% | 11 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $116 → $115 | $84.06 | +36.81% | 2 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $94.22 | +12.50% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $470 → $550 | $441.12 | +24.68% | 13 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $116 → $128 | $91.69 | +39.60% | 7 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $62 → $68 | $67.21 | +1.18% | 15 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $29.99 | +53.38% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $226 | $184.84 | +22.27% | 3 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $16 | $14.50 | +10.34% | 9 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $42 | $21.98 | +91.08% | 7 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $44 → $49 | $49.44 | -0.89% | 6 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $3.20 | -6.25% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $96 → $85 | $72.46 | +17.31% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $110 → $112 | $98.18 | +14.08% | 6 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $207 → $202 | $134.46 | +50.23% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $12.89 | +132.74% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $291.71 | +21.70% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $26.91 | +108.10% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $64.51 | +148.02% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $184.60 | +57.10% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.53 | +357.85% | 1 | May 31, 2022 |
iRhythm Technologies
Sep 23, 2025
Initiates: In-Line
Price Target: $185
Current: $170.81
Upside: +8.31%
Penumbra
Sep 2, 2025
Initiates: Outperform
Price Target: $300
Current: $253.37
Upside: +18.40%
Agilent Technologies
Aug 28, 2025
Maintains: In-Line
Price Target: $130 → $128
Current: $123.39
Upside: +3.74%
Caris Life Sciences
Aug 13, 2025
Maintains: Outperform
Price Target: $33 → $40
Current: $29.19
Upside: +37.03%
Exact Sciences
Aug 8, 2025
Maintains: Outperform
Price Target: $68 → $64
Current: $53.57
Upside: +19.47%
Azenta
Aug 5, 2025
Maintains: In-Line
Price Target: $35 → $33
Current: $28.54
Upside: +15.63%
Mettler-Toledo International
Aug 4, 2025
Maintains: Outperform
Price Target: $1,280 → $1,275
Current: $1,204.43
Upside: +5.86%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $18 → $16
Current: $11.84
Upside: +35.14%
Edwards Lifesciences
Jul 25, 2025
Maintains: In-Line
Price Target: $77 → $80
Current: $76.25
Upside: +4.92%
Abbott Laboratories
Jul 17, 2025
Maintains: Outperform
Price Target: $145 → $140
Current: $133.55
Upside: +4.83%
Jul 8, 2025
Maintains: In-Line
Price Target: $102 → $96
Current: $98.24
Upside: -2.28%
Jul 8, 2025
Maintains: Outperform
Price Target: $500 → $480
Current: $464.24
Upside: +3.39%
Jul 8, 2025
Maintains: Outperform
Price Target: $390 → $415
Current: $369.02
Upside: +12.46%
Jul 8, 2025
Maintains: Outperform
Price Target: $116 → $115
Current: $84.06
Upside: +36.81%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $94.22
Upside: +12.50%
Jul 8, 2025
Maintains: In-Line
Price Target: $470 → $550
Current: $441.12
Upside: +24.68%
Jul 8, 2025
Maintains: Outperform
Price Target: $116 → $128
Current: $91.69
Upside: +39.60%
Jul 8, 2025
Maintains: In-Line
Price Target: $62 → $68
Current: $67.21
Upside: +1.18%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $29.99
Upside: +53.38%
Jul 8, 2025
Maintains: Outperform
Price Target: $230 → $226
Current: $184.84
Upside: +22.27%
Jul 8, 2025
Maintains: Outperform
Price Target: $16 → $16
Current: $14.50
Upside: +10.34%
Jul 8, 2025
Maintains: Outperform
Price Target: $44 → $42
Current: $21.98
Upside: +91.08%
Jun 4, 2025
Maintains: In-Line
Price Target: $44 → $49
Current: $49.44
Upside: -0.89%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $3.20
Upside: -6.25%
May 1, 2025
Maintains: Outperform
Price Target: $96 → $85
Current: $72.46
Upside: +17.31%
Apr 24, 2025
Maintains: Outperform
Price Target: $110 → $112
Current: $98.18
Upside: +14.08%
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $134.46
Upside: +50.23%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $12.89
Upside: +132.74%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $291.71
Upside: +21.70%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $26.91
Upside: +108.10%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $64.51
Upside: +148.02%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $184.60
Upside: +57.10%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.53
Upside: +357.85%